Home » Topics » Medical technology

Medical technology
RSS

Eurogene Acquires Quattrogene, Phase II Product In Stock Deal

Jan. 31, 2001

NV Organon Agrees To Develop Cortex's Product For Depression

Jan. 31, 2001

Large Scale, Biosite Partner To Develop Antibody Arrays

Jan. 31, 2001

Other News To Note

Jan. 31, 2001

New UK BIA Chairman Pushes Industry To Go On Offensive

Jan. 31, 2001

Incyte, Oxagen Collaborate To Crack Genetics Of Osteoporosis

Jan. 30, 2001

Appointments and Advancements

Jan. 30, 2001

Other News To Note

Jan. 30, 2001

Correction

Jan. 30, 2001

Chiron Sees Positive Trends In Phase II Study Of FGF-2

Jan. 30, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...